PR001

· Prevail Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PR001, covering 2026-04-01 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2 Clinical Trial of PR001 in Infants With Type 2 Gaucher Disease (PROVIDE) [Phase 1, Phase 2]